DPA, EPA, and DHA: The Three Omega-3 Fatty Acids That Matter
Most people know about EPA and DHA — the two omega-3 fatty acids in fish oil supplements. But there is a third one that rarely appears on labels: DPA (docosapentaenoic acid). New research suggests DPA may be as important as its better-known siblings. This guide explains what each one does, how they differ, and whether you should care about DPA content when buying fish oil.
Who This Is For
Anyone who takes or is considering omega-3 supplements and wants to understand what they are actually putting in their body. After reading, you will know the specific role of each omega-3 type, how to read supplement labels properly, and whether DPA-enriched products are worth the premium.
TL;DR
- EPA (eicosapentaenoic acid, 20:5n-3): Primarily anti-inflammatory. Reduces triglycerides and supports cardiovascular health (Mozaffarian & Wu, 2011)
- DHA (docosahexaenoic acid, 22:6n-3): Brain and retina structural component. Critical during pregnancy and aging (Dyall, 2015)
- DPA (docosapentaenoic acid, 22:5n-3): The "bridge" fatty acid — converts to both EPA and DHA in the body and has unique anti-inflammatory properties (Kaur et al., 2011)
- Standard fish oil contains 2–5% DPA alongside EPA and DHA, but it is rarely listed on labels
- Seal oil and certain premium fish oils have higher DPA content (8–15%)
- For most people, a standard high-quality fish oil with good EPA+DHA content is sufficient
Understanding the Three Omega-3s
EPA: The Anti-Inflammatory
EPA (eicosapentaenoic acid) is a 20-carbon omega-3 fatty acid. Its primary role is as a precursor to anti-inflammatory eicosanoids — signaling molecules that regulate inflammation throughout the body. EPA competes with arachidonic acid (AA, an omega-6) for the same enzymatic pathways, effectively shifting the balance from pro-inflammatory to anti-inflammatory mediators (Calder, 2017).
Clinical evidence for EPA is strongest in cardiovascular health. The REDUCE-IT trial (Bhatt et al., 2019) demonstrated that 4 g/day of icosapent ethyl (a purified EPA supplement) reduced major cardiovascular events by 25% in high-risk patients already on statin therapy. EPA also consistently lowers triglyceride levels by 15–30% at doses of 2–4 g/day (Mozaffarian & Wu, 2011).
Beyond cardiology, EPA shows promise for mood disorders. A meta-analysis by Sublette et al. (2011) found that omega-3 supplements with EPA ≥ 60% of total content showed significant antidepressant effects compared to placebo.
Key takeaway: EPA is your inflammation fighter and cardiovascular protector.
DHA: The Brain Builder
DHA (docosahexaenoic acid) is a 22-carbon omega-3 and the most abundant omega-3 in the brain, comprising approximately 40% of polyunsaturated fatty acids in the cerebral cortex (Dyall, 2015). It is also the primary omega-3 in the retina.
DHA serves structural rather than signaling functions. It integrates into cell membrane phospholipids, increasing membrane fluidity and facilitating neurotransmitter receptor function. This is why DHA is critical during two life stages:
1. Fetal development and infancy: DHA accumulates rapidly in the fetal brain during the third trimester. Maternal DHA supplementation during pregnancy is associated with improved cognitive development and visual acuity in infants (Coletta et al., 2010).
2. Cognitive aging: Low DHA status is associated with increased risk of cognitive decline and Alzheimer's disease. The MIDAS trial showed that 900 mg/day of DHA improved learning and memory in healthy older adults with age-related cognitive decline (Yurko-Mauro et al., 2010).
Key takeaway: DHA is your brain and eye structural material.
DPA: The Overlooked Third Player
DPA (docosapentaenoic acid) is a 22-carbon omega-3 that sits metabolically between EPA and DHA. It has been called the "bridge" fatty acid because the body can convert DPA to both EPA and DHA as needed (Kaur et al., 2011).
DPA has received less research attention than EPA or DHA, partly because it was difficult to isolate in pure form for clinical trials. However, the evidence is accumulating:
- Higher biological potency per unit: Kaur et al. (2013) found that DPA inhibited platelet aggregation at 10-fold lower concentrations than EPA, suggesting greater anti-thrombotic potency.
- Unique anti-inflammatory mediators: DPA gives rise to its own family of specialized pro-resolving mediators (SPMs) that are distinct from those produced by EPA or DHA (Dalli et al., 2013).
- Endothelial repair: DPA promotes migration of endothelial cells (the cells lining blood vessels), potentially aiding in vascular repair — an effect not observed with EPA or DHA (Kaur et al., 2011).
- Epidemiological support: In the Framingham Heart Study, higher plasma DPA levels were independently associated with lower total mortality risk, even after adjusting for EPA and DHA levels (Mozaffarian et al., 2013).
Key takeaway: DPA is not just a metabolic intermediate — it has its own distinct benefits.
Head-to-Head Comparison
| Feature | EPA (20:5n-3) | DHA (22:6n-3) | DPA (22:5n-3) |
|---|---|---|---|
| Primary role | Anti-inflammatory signaling | Brain/retina structure | Bridge + unique anti-inflammatory |
| Best for | Heart health, triglycerides, mood | Brain development, cognition, eyes | Vascular repair, platelet regulation |
| Typical fish oil content | 18–33% | 12–22% | 2–5% |
| Clinical evidence level | Extensive (multiple large RCTs) | Extensive (RCTs + epidemiology) | Emerging (epidemiology + mechanistic) |
| Converts to others? | No | No | Yes — to both EPA and DHA |
| Found in highest amounts in | Fatty fish, algae | Fatty fish, algae | Seal oil, meat, certain fish |
Practical Dosing
For general health, focus on combined EPA+DHA. DPA is a bonus, not a requirement.
| Goal | EPA target | DHA target | DPA consideration |
|---|---|---|---|
| General health | 250–500 mg | 250–500 mg | Not critical |
| Cardiovascular protection | 1,000–2,000 mg | 500–1,000 mg | Beneficial if available |
| Brain health / aging | 500 mg | 900–1,000 mg | Beneficial |
| Pregnancy / lactation | 200–300 mg | 300–600 mg | Not critical |
| Inflammation / recovery (athletes) | 1,500–2,000 mg | 500–1,000 mg | Beneficial |
Where DPA Comes From
Standard fish oil from anchovies, sardines, and mackerel contains 2–5% DPA naturally. You are already getting some even if the label does not list it. Products specifically enriched with DPA include:
- Seal oil: Naturally contains 4–5% DPA alongside EPA and DHA. The ratio is roughly 1:1:1 (EPA:DPA:DHA), unlike fish oil where EPA and DHA dominate.
- Premium concentrated fish oils: Some manufacturers now highlight DPA content on labels.
- Menhaden oil: Contains relatively higher DPA than standard fish oils.
How to Read Labels: A Practical Guide
Most fish oil labels show total fish oil weight and a breakdown of EPA and DHA. Here is what to watch for:
1. Per capsule vs. per serving. Some products list nutrients per 2–3 capsule serving. Always check per single capsule.
2. "Omega-3" vs. EPA+DHA. Total omega-3 includes minor fatty acids (ALA, DPA, SDA, etc.). The number that matters is EPA + DHA combined.
3. Form matters. Triglyceride (TG) and re-esterified triglyceride (rTG) forms absorb 70% better than ethyl esters (EE) (Dyerberg et al., 2010).
4. DPA if listed. A bonus, but don't pay a large premium just for DPA. The conversion from DPA to EPA/DHA makes standalone DPA supplementation less necessary.
Example Label Breakdown
| Label claim | What it means |
|---|---|
| "Fish oil 1,000 mg" | Total weight of oil in capsule (includes filler fats) |
| "Omega-3: 600 mg" | Total omega-3 content (EPA + DHA + others) |
| "EPA: 360 mg" | Active anti-inflammatory omega-3 |
| "DHA: 240 mg" | Active brain/structure omega-3 |
| Unlisted DPA | Likely 20–50 mg present but not declared |
Common Mistakes
1. Obsessing over DPA at the expense of EPA+DHA. DPA research is promising but still early-stage. Getting adequate EPA and DHA is far more important than hunting for DPA-enriched products.
2. Assuming all fish oils are equal. Concentration varies enormously. A 1,000 mg capsule might deliver 300 mg or 800 mg of actual EPA+DHA depending on the product.
3. Taking too little. The most common mistake is under-dosing. One standard fish oil capsule per day provides only 300 mg EPA+DHA — below the minimum recommended for cardiovascular benefit.
4. Ignoring the EPA:DHA ratio for your goal. Cardiovascular and anti-inflammatory goals call for higher EPA. Brain and cognitive goals call for higher DHA. Generic products split roughly 60:40 EPA:DHA, which works for general health.
5. Not taking with fat-containing food. Omega-3 absorption increases significantly when taken with a fat-containing meal (Schuchardt & Hahn, 2013).
FAQ
Is DPA just EPA or DHA in disguise?
No. While DPA can be converted to EPA and DHA, it also has unique biological activities that neither EPA nor DHA possess — including distinct pro-resolving mediators and endothelial repair properties (Dalli et al., 2013; Kaur et al., 2011). Think of it as a multipurpose molecule with its own job description plus the ability to cover for its siblings.
Should I buy seal oil instead of fish oil for the DPA?
Seal oil provides a more balanced EPA:DPA:DHA ratio, but it is less researched than fish oil and often more expensive. For most people, a high-quality concentrated fish oil providing adequate EPA+DHA is the better value. The natural DPA in fish oil (2–5%) likely provides sufficient DPA for general health.
Can I get DPA from plant sources?
Practically no. DPA (22:5n-3) is found almost exclusively in animal marine sources. Plant omega-3s (ALA from flax, chia, walnuts) can theoretically convert to DPA, but conversion efficiency is very low — typically under 5% (Burdge & Calder, 2005).
Does cooking destroy DPA, EPA, or DHA?
High-heat cooking (frying) can oxidize and degrade omega-3 fatty acids. Baking and steaming preserve them reasonably well. However, supplement capsules are not cooked, so this is mainly relevant for whole fish consumption. Store fish oil capsules in a cool, dark place to prevent oxidation.
How do I know if I am getting enough total omega-3?
Without a blood test, you cannot be sure. The Omega-3 Index test measures the percentage of EPA+DHA in red blood cell membranes. An index of 8–12% is considered optimal, while below 4% indicates deficiency and elevated cardiovascular risk (Harris & Von Schacky, 2004). The test costs approximately €40–60 and is available in some Estonian labs.
Estonia-Specific Context
Estonia's cold-water fish heritage (Baltic herring, sprat) means some traditional diets provide decent omega-3 intake. However, modern Estonian diets have shifted toward processed foods, and the average omega-3 intake falls below recommendations.
Fish oil products in Estonia range from €8–12 for basic formulations (typically 300 mg EPA+DHA per capsule) to €18–30 for concentrated products (600–800 mg EPA+DHA per capsule). The price per gram of actual EPA+DHA — not per capsule — is the metric that matters. MaxFit.ee offers concentrated options from European and international brands with clear label transparency.
Baltic herring (räim) and sprat (kilu) remain excellent whole-food omega-3 sources. A 100g serving of herring provides roughly 1,500–2,000 mg of EPA+DHA — equivalent to 5–7 standard fish oil capsules.
References
1. Mozaffarian, D. & Wu, J.H.Y. (2011). Omega-3 fatty acids and cardiovascular disease. Journal of the American College of Cardiology, 58(20), 2047–2067.
2. Dyall, S.C. (2015). Long-chain omega-3 fatty acids and the brain. Annual Review of Nutrition, 35, 571–598.
3. Kaur, G., Cameron-Smith, D., Garg, M. & Sinclair, A.J. (2011). Docosapentaenoic acid (22:5n-3): a review of its biological effects. Progress in Lipid Research, 50(1), 28–34.
4. Calder, P.C. (2017). Omega-3 fatty acids and inflammatory processes. Nutrients, 9(3), 263.
5. Bhatt, D.L., Steg, P.G., Miller, M. et al. (2019). Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New England Journal of Medicine, 380(1), 11–22.
6. Sublette, M.E., Ellis, S.P., Geant, A.L. & Mann, J.J. (2011). Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. Journal of Clinical Psychiatry, 72(12), 1577–1584.
7. Coletta, J.M., Bell, S.J. & Roman, A.S. (2010). Omega-3 fatty acids and pregnancy. Reviews in Obstetrics and Gynecology, 3(4), 163–171.
8. Yurko-Mauro, K., McCarthy, D., Rom, D. et al. (2010). Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's & Dementia, 6(6), 456–464.
9. Kaur, G., Guo, X.F. & Sinclair, A.J. (2013). Short update on docosapentaenoic acid: a bioactive long-chain n-3 fatty acid. Current Opinion in Clinical Nutrition and Metabolic Care, 19(2), 88–91.
10. Dalli, J., Colas, R.A. & Serhan, C.N. (2013). Novel n-3 immunoresolvents: structures and actions. Scientific Reports, 3, 1940.
11. Mozaffarian, D., Lemaitre, R.N., King, I.B. et al. (2013). Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults. Annals of Internal Medicine, 158(7), 515–525.
12. Dyerberg, J., Madsen, P., Møller, J.M., Aardestrup, I. & Schmidt, E.B. (2010). Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes and Essential Fatty Acids, 83(3), 137–141.
13. Schuchardt, J.P. & Hahn, A. (2013). Bioavailability of long-chain omega-3 fatty acids. Prostaglandins, Leukotrienes and Essential Fatty Acids, 89(1), 1–8.
14. Burdge, G.C. & Calder, P.C. (2005). Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction Nutrition Development, 45(5), 581–597.
15. Harris, W.S. & Von Schacky, C. (2004). The Omega-3 Index: a new risk factor for death from coronary heart disease? Preventive Medicine, 39(1), 212–220.
See also:
- Marine Forte Omega-3: What It Contains and Is It Worth It?
- High-EPA Omega-3 for Lipid Regulation: A Science-Based Guide to Targeted Fish Oil Supplementation
- EPA and DHA 1000 mg: What the Label Numbers Actually Mean
---
Browse omega-3 products at MaxFit.ee →
See also:
